Scientists working on a diabetes drug discovered an unexpected side effect: it made people not want to eat. The resulting once-weekly injections, known as Ozempic and Wegovy, have transformed Denmark's Novo Nordisk into one of Europe's largest companies.
The drugs are so popular that demand has soared, leading to shortages. But they're not cheap, and many patients cannot afford them.
We are a...
Download App Shofney
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek